Clinical Trial

Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
This trial was designed to evaluate the efficacy and safety of SHR-1819 injection in patients with Prurigo Nodularis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-13; most recent amendment 2026-04-23.
Status change: Not Yet Recruiting → Recruiting 2024-10-08
Trial Details
NCT Number NCT06554509
Lead Sponsor Guangdong Hengrui Pharmaceutical Co., Ltd
Conditions Prurigo Nodularis
Enrollment 423 participants
Start Date 2024-09-19
Primary Completion 2028-10 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-29